对处于数字媒体使用障碍高风险的青少年进行混合数字健康干预:Res@t-Consortium中随机对照试验的协议
Oliver Labrenz1,2, Lucie Waedel1,2, Michael Kölch1,2
1Department of Child and Adolescent Psychiatry, Neurology, Psychosomatics, and Psychotherapy, University Medical Center Rostock, Rostock, Germany.
Frontiers in psychiatry
|February 4, 2025
概括
数字媒体使用障碍 (DMUD) 影响年轻人,特别是那些在福利制度. 一个基于应用程序的计划,Res@t digital,旨在减少DMUD症状,并改善面临风险的年轻人的媒体习惯.
科学领域:
- 精神病学是一个精神病学.
- 数字健康数字健康
- 儿童和青少年健康 儿童和青少年健康
背景情况:
- 数字媒体使用障碍 (DMUD) 对年轻人构成重大挑战,导致功能障碍和心理问题.
- 在儿童和青少年福利系统中的儿童和青少年面临更高的心理健康障碍风险,包括DMUD,并且不太可能获得传统治疗.
- 需要有针对性的干预措施来解决DMUD在脆弱的年轻人群.
研究的目的:
- 评估Res@t基于数字应用程序的培训计划在减少DMUD症状方面的有效性.
- 改善儿童和青少年被诊断患有或有DMUD风险的媒体使用行为.
- 评估应用程序对参与儿童和青少年福利服务的家庭的实用性.
主要方法:
- 一个随机对照试验 (RCT) 与等候名单对照组将评估Res@t数字应用程序的有效性.
- 该研究包括32名患有DMUD或有风险的儿童和青少年及其家属.
- 主要结局是在20周内减少DMUD症状;次要结局包括EEG和精神病变量.
主要成果:
- 该研究旨在确定Res@t应用程序是否与等候名单对照相比显著减少DMUD症状.
- EEG测量和标准化精神病理变量将进一步了解该应用程序的影响.
- 结果将表明该应用程序作为独立或辅助治疗的潜力.
结论:
- 如果有效,Res@t数字可以为儿科DMUD提供基于证据的干预措施.
- 该应用程序可能会激励高风险家庭解决DMUD,并促进进一步治疗的机会.
- 这个数字健康工具有可能改善风险青少年的心理健康结果.
相关概念视频
01:13Randomized Experiments
6.7K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.7K
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
01:12Hazard Ratio
78
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
78
02:01Group Design
8.9K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
8.9K